Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Zollinger-Ellison Syndrome 2Gastroesophageal Reflux 2Barrett Esophagus 2Xerostomia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Pseudomyxoma Peritonei 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia 1Mucositis 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, B-Cell 1Hemorrhage 1Heartburn 1Head and Neck Neoplasms 1Esophagitis, Peptic 1Endometrial Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoid Tumor 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Lansoprazole × Clear all
NCT02150447 2018-04-04

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

National Cancer Center, Korea

Phase 3 Terminated
394 enrolled
Gastrointestinal

Hemorrhage, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡